217 related articles for article (PubMed ID: 32017057)
1. Systemic redox imbalance in patients with nonalcoholic fatty liver disease.
Asghari S; Hamedi-Shahraki S; Amirkhizi F
Eur J Clin Invest; 2020 Apr; 50(4):e13211. PubMed ID: 32017057
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients.
Świderska M; Maciejczyk M; Zalewska A; Pogorzelska J; Flisiak R; Chabowski A
Free Radic Res; 2019 Aug; 53(8):841-850. PubMed ID: 31234658
[TBL] [Abstract][Full Text] [Related]
3. Effects of Calorie Restricted Diet on Oxidative/Antioxidative Status Biomarkers and Serum Fibroblast Growth Factor 21 Levels in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Controlled Clinical Trial.
Asghari S; Rezaei M; Rafraf M; Taghizadeh M; Asghari-Jafarabadi M; Ebadi M
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745238
[TBL] [Abstract][Full Text] [Related]
4. Oxidative Stress and Nonalcoholic Fatty Liver Disease in Hemodialysis Patients.
Wu PJ; Chen JB; Lee WC; Ng HY; Lien SC; Tsai PY; Wu CH; Lee CT; Chiou TT
Biomed Res Int; 2018; 2018():3961748. PubMed ID: 30515395
[TBL] [Abstract][Full Text] [Related]
5. Effects of Pharmacologic Dose of Resveratrol Supplementation on Oxidative/Antioxidative Status Biomarkers in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.
Asghari S; Rafraf M; Farzin L; Asghari-Jafarabadi M; Ghavami SM; Somi MH
Adv Pharm Bull; 2018 Jun; 8(2):307-317. PubMed ID: 30023333
[No Abstract] [Full Text] [Related]
6. Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis.
Spahis S; Delvin E; Borys JM; Levy E
Antioxid Redox Signal; 2017 Apr; 26(10):519-541. PubMed ID: 27452109
[TBL] [Abstract][Full Text] [Related]
7. Atherogenic changes of low-density lipoprotein susceptibility to oxidation, and antioxidant enzymes in pulmonary tuberculosis.
Nezami N; Ghorbanihaghjo A; Rashtchizadeh N; Argani H; Tafrishinejad A; Ghorashi S; Hajhosseini B
Atherosclerosis; 2011 Jul; 217(1):268-73. PubMed ID: 21497814
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the superoxide dismutase by malondialdehyde in the nonalcoholic fatty liver disease: a combined molecular docking approach to clinical studies.
Arya A; Azarmehr N; Mansourian M; Doustimotlagh AH
Arch Physiol Biochem; 2021 Dec; 127(6):557-564. PubMed ID: 31475569
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease.
Orem A; Yandi YE; Vanizor B; Cimşit G; Uydu HA; Malkoç M
Clin Biochem; 2002 May; 35(3):217-24. PubMed ID: 12074830
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
Samy W; Hassanian MA
Arab J Gastroenterol; 2011 Jun; 12(2):80-5. PubMed ID: 21684478
[TBL] [Abstract][Full Text] [Related]
11. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
Jiang Y; Chen L; Wang H; Narisi B; Chen B
J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089
[TBL] [Abstract][Full Text] [Related]
12. Weight loss enhances hepatic antioxidant status in a NAFLD model induced by high-fat diet.
Mendes IKS; Matsuura C; Aguila MB; Daleprane JB; Martins MA; Mury WV; Brunini TMC
Appl Physiol Nutr Metab; 2018 Jan; 43(1):23-29. PubMed ID: 28834687
[TBL] [Abstract][Full Text] [Related]
13. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease.
Köroğlu E; Canbakan B; Atay K; Hatemi İ; Tuncer M; Dobrucalı A; Sonsuz A; Gültepe I; Şentürk H
Turk J Gastroenterol; 2016 Jul; 27(4):361-6. PubMed ID: 27458852
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol inhibits nonalcoholic fatty liver disease in rats.
Bujanda L; Hijona E; Larzabal M; Beraza M; Aldazabal P; García-Urkia N; Sarasqueta C; Cosme A; Irastorza B; González A; Arenas JI
BMC Gastroenterol; 2008 Sep; 8():40. PubMed ID: 18782455
[TBL] [Abstract][Full Text] [Related]
15. The effect of 12 week-maximum fat oxidation intensity (FATmax) exercise on microvascular function in obese patients with nonalcoholic fatty liver disease and its mechanism.
Yang R; Wan L; Zhu H; Peng Y
Gen Physiol Biophys; 2023 May; 42(3):251-262. PubMed ID: 37098738
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease.
Liu W; Baker SS; Baker RD; Zhu L
Curr Drug Targets; 2015; 16(12):1301-14. PubMed ID: 25915484
[TBL] [Abstract][Full Text] [Related]
17. Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis.
Kumar A; Sharma A; Duseja A; Das A; Dhiman RK; Chawla YK; Kohli KK; Bhansali A
J Clin Exp Hepatol; 2013 Mar; 3(1):12-8. PubMed ID: 25755466
[TBL] [Abstract][Full Text] [Related]
18. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
Serviddio G; Bellanti F; Vendemiale G
Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
[TBL] [Abstract][Full Text] [Related]
19. Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease.
Perlemuter G; Davit-Spraul A; Cosson C; Conti M; Bigorgne A; Paradis V; Corre MP; Prat L; Kuoch V; Basdevant A; Pelletier G; Oppert JM; Buffet C
Liver Int; 2005 Oct; 25(5):946-53. PubMed ID: 16162151
[TBL] [Abstract][Full Text] [Related]
20. A Decreased Response to Resistin in Mononuclear Leukocytes Contributes to Oxidative Stress in Nonalcoholic Fatty Liver Disease.
Garcia CC; Piotrkowski B; Baz P; Poncino D; Benavides J; Colombato L; Toso MLR; Yantorno S; Descalzi V; Gondolesi GE; Fraga CG; Cherñavsky AC
Dig Dis Sci; 2022 Jul; 67(7):3006-3016. PubMed ID: 34156590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
